New Weight Loss Drug Could Break Sales Records One News Page Video The fda is expected to approve the diabetes drug tirzepatide for weight loss, but questions over pricing remain.» subscribe to nbc news: nbcnews.to su. An experimental drug from eli lilly helped patients with obesity lose an average of 24% of their body weight over 48 weeks on the highest dose in a mid stage study, the most weight loss seen yet.
New Weight Loss Drug Could Break Sales Records If the fda confirms the drug’s effectiveness, a “fair” price for tirzepatide could be around $13,000 annually, or around $1,100 a month, said dr. david rind, the chief medical officer for. The experimental drug, retatrutide, helped people lose, on average, about 24% of their body weight, the equivalent of about 58 pounds, in a mid stage clinical trial, the company said monday from. New weight loss drug could break sales records. videos cannot play due to a network issue. please check your internet connection and try again. the fda is expected to approve the diabetes drug. This new drug, semaglutide, was first approved for diabetes in 2017 under the brand name ozempic and then in 2021 for weight loss as wegovy. in trials of the drug, participants who received wegovy.
Comments are closed.